Gastroenterology

Gastroenterology

Volume 104, Issue 5, May 1993, Pages 1492-1497
Gastroenterology

Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients

https://doi.org/10.1016/0016-5085(93)90361-FGet rights and content

Abstract

Background:Patients with liver cirrhosis disclose both increased production and decreased metabolism of tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6). The present study analyzes the characteristic pattern of these cytokines during sepsis in cirrhotics. Methods: TNF-α and IL-6 plasma levels, measured during 15 days from the onset of cirrhotic decompensation or of the septic event, were compared between 14 infected patients with liver cirrhosis, 18 uninfected decompensated cirrhotic patients, and 35 septicemic patients devoid of liver disease. Cytokines were measured using immunoassays. Results: In infected cirrhotics, initial levels of both TNF-α and IL-6 were significantly higher than in noninfected cirrhotic patients (P < 0.0001) or in septicemic patients devoid of cirrhosis (P < 0.001). Initial IL-6 plasma levels (threshold, 200 pg/mL) showed 89% specificity and 100% sensitivity in discriminating cirrhotic decompensation due to infection from that caused by other factors. TNF-α and IL-6 plasma levels remained significantly higher for many days in infected cirrhotic patients compared with the other two groups. Conclusions: Both the profoundly increased initial levels of TNF-α and IL-6 and their persistence over days after sepsis onset seem characteristic of the cirrhotic patients. The exact relationship between prolonged exposure to TNF-α and poor prognosis in these patients is unknown, but it might represent a unique opportunity for the use of anti-TNF-α antibodies during sepsis.

References (36)

  • A Khoruts et al.

    Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients

    Hepatology

    (1991)
  • J Devière et al.

    High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production

    Clin Exp Immunol

    (1989)
  • JV Castell et al.

    Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat

    Eur J Biochem

    (1988)
  • O Sonne et al.

    Cellular targets and receptors for interleukin-6. In vivo and in vitro uptake of IL-6 in liver and hepatocytes

    Eur J Clin Invest

    (1990)
  • E Girardin et al.

    Tumor necrosis factor and Interleukin-1 in the serum of children with severe infectious purpura

    N Engl J Med

    (1988)
  • MA Marano et al.

    Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality

    Surg Gynecol Obstet

    (1990)
  • MA de Groote et al.

    Plasma tumor necrosis factor levels in patients with presumed sepsis

    JAMA

    (1989)
  • KJ Tracey et al.

    Shock and tissue injury induced by recombinant human cachectin

    Science

    (1986)
  • Cited by (0)

    View full text